Aneuploidy-cancer predisposition syndromes: A new link between the mitotic spindle checkpoint and cancer

Cell Cycle

Volumn 4, Issue 2, 2005, Pages 228-230

  Hanks, Sandra ^a   Rahman, Nazneen ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Aneuploidy; BUB1B; BUBR1; Cancer; Mitotic spindle checkpoint; Mosaic variegated aneuploidy

Indexed keywords

BUB1 RELATED PROTEIN; BUB1B PROTEIN; BUB3 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANEUPLOIDY; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE INHERITANCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CATALYSIS; CATARACT; CHILDHOOD CANCER; CHROMOSOME; FAMILIAL CANCER; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE INSERTION; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; HUMAN; LEUKEMIA; MICROCEPHALY; MOSAIC VARIEGATED ANEUPLOIDY SYNDROME; NEPHROBLASTOMA; ONCOGENE; PHENOTYPE; POINT MUTATION; RHABDOMYOSARCOMA; SHORT SURVEY; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 25444501240     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.2.1419     Document Type: Short Survey

References (24)

1. Lengauer C, Kinzler K, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396:643-9.
2. Duesberg P, Li R. Multistep carcinogenesis: A chain reaction of aneuploidizations. Cell Cycle 2003; 2:202-10.
3. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004; 4:177-83.
4. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Medicine 2004; 10:789-99.
5. Balmain A, Cancer genetics: From Boveri and Mendel to microarrays. Nat Rev Cancer 2001; 1:77-82.
6. Mussachio A, Hardwick KG. The spindle checkpoint: Structural insights into dynamic signalling. Nat Rev Mol Cell Biol 2002; 3:731-41.
7. Bharadwaj R, Yu H. The spindle checkpoint, aneuploidy and cancer. Oncogene 2004; 23:2016-27.
8. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature 1998; 392:300-3.
9. Matsuura S, Ito E, Tauchi H, Komatsu K, Ikeuchi T, Kajii T. Chromosomal instability syndrome of total premature chromatid separation with mosaic variegated aneuploidy is defective in mitotic spindle checkpoint. Am J Hum Genet 2000; 67:483-86.
10. Jacquemont S, Boceno M, Rival JM, Mechinaud F, David A. High risk of malignancy in mosaic variegated aneuploidy syndrome. Am J Med Genet 2002; 109:17-21.
11. Hanks S, Coleman K, Reid S, Plaja A, Firth H, FitzPatrick D, Kidd A, Mehes K, Nash R, Robin N, Shannon N, Tolmie J, Swansbury J, Irrthum A, Douglas J, Rahman N. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 2004; 36:1159-61.
12. Rahman N, Stratton MR. Breast cancer susceptibility genes. Ann Rev Genet 1998; 32:95-121.
13. Sato M, Sekido Y, Horio Y, Takahashi M, Saito H, Minna JD, Shimokata K, Hasegawa Y. Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer. Jpn J Cancer Res 2000; 91:504-9.
14. Reis RM, Nakamura M, Masuoka J, Watanabe T, Colella S, Yoneka Y, Kleihues P, Ohgaki H. Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas. Acta neuropathol 2001; 101:297-304.
15. Shichiri M, Yoshinaga K, Hisatomi H, Sugihara K, Hirata Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res 2002; 62:13-7.
16. Lucci-Corisco E, Zito I, Gensini F, Genuardi M. Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet 2003; 122A:325-34.
17. Reid S, Renwick A, Seal S, Baskcomb L, Barfoot R, Jayatilake H. Familial Wilms Tumour Collaboration, Breast Cancer Susceptibility Collaboration (UK). In: Pritchard-Jones K, Stratton MR, Ridolfi-Lüthy A, Rahman N, eds. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood, including familial Wilms tumour. J Med Genet 2005; In press.
18. Cavaciuti E, Lauge A, Janin N, Ossian K, Hall J, Stoppa-Lyonnet D, Andrieu N. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families. Genes Chromosomes Cancer 2005; 42:1-9.
19. Taylor SS, Ha E, McKeon F. The human homologue of bub3 Is required for kinetochore localization of bub1 and a mad3/bub1-related protein kinase. Cell Biol 1998; 142:1-11.
20. Tang Z, Bharadwaj R, Li B, Yu H. Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1. Dev Cell 2001; 1:227-37.
21. Mao Y, Abrieu A, Cleveland DW. Activating and silencing the mitotic checkpoint through CENP-E-dependent activation/inactivation of BubR1. Cell 2003; 114:87-98.
22. Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S, Mahmood R, Yang YM, Xu M, Rao CV. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploin-sufficiency. Cancer Res 2004; 64:440-5.
23. Wang Q, Liu T, Fang Y, Xie S, Huang X, Mahmood R, Ramaswamy G, Sakamoto KM, Darzynkiewicz Z, Xu M, Dai W. BUBR1 deficiency results in abnormal megakaryopoiesis. Blood 2004; 103:1278-85.
24. Baker DJ, Jenganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A, Kumar R, Jenkins RB, de Groen PC, Roche P, van Deursen JM. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 2004; 36:744-9.